Biodexa Pharmaceuticals promotes Fiona Sharp to CFO, secretary [Yahoo! Finance]
Biodexa Pharmaceuticals plc - American Depositary Shares (BDRX)
Company Research
Source: Yahoo! Finance
Sharp is a senior finance professional having joined the Company as Group Financial Controller in December 2019. During her tenure, she has consistently broadened her remit to include many of the responsibilities of a CFO. Stephen Stamp will relinquish his roles as CFO and Company Secretary but remain as CEO. Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now See the top stocks recommended by analysts Read More on BDRX: Disclaimer & Disclosure Report an Issue Biodexa Pharmaceuticals Prices $10 Million U.S. Public Offering to Fund Pipeline Biodexa Pharmaceuticals prices 157,000 units at $3.28 in public offering Biodexa Pharmaceuticals PLC-ADR trading resumes Biodexa Pharmaceuticals PLC-ADR trading halted, volatility tradin
Show less
Read more
Impact Snapshot
Event Time:
BDRX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BDRX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BDRX alerts
High impacting Biodexa Pharmaceuticals plc - American Depositary Shares news events
Weekly update
A roundup of the hottest topics
BDRX
News
- Appointment of Fiona Sharp to the Board as Chief Financial Officer and Company Secretary [Yahoo! Finance]Yahoo! Finance
- Appointment of Fiona Sharp to the Board as Chief Financial Officer and Company SecretaryGlobeNewswire
- Biodexa Pharmaceuticals (NASDAQ:BDRX) was upgraded by analysts at <a style="font-weight:bold" href="https://www.wallstreetzen.com/newsletters/zen-ratings?ticker=BDRX&utm_campaign=getratings&utm_medium=online&utm_source=MarketBeat">Wall SMarketBeat
- Biodexa Announces Pricing of $10 Million Public OfferingGlobeNewswire
- Biodexa Announces Enrolment of First European Patients into Pivotal Phase 3 Serenta Trial in FAPGlobeNewswire
BDRX
Sec Filings
- 1/6/26 - Form 424B3
- 1/6/26 - Form 424B3
- 1/6/26 - Form 424B3
- BDRX's page on the SEC website